87 related articles for article (PubMed ID: 17699215)
41. Expression of transforming growth factor beta1 gene, basic fibroblast growth factor gene and hydroxyproline in diabetes-induced bladder dysfunction in a rat model.
Yongzhi L; Benkang S; Jianping Z; Lingxia R; Wei B; Yaofeng Z; Keqin Z; Laudon V
Neurourol Urodyn; 2008; 27(3):254-9. PubMed ID: 17763394
[TBL] [Abstract][Full Text] [Related]
42. Effect of TGF-beta1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats.
Hiong LC; Voon KL; Abdullah NA; Sattar MA; Rahman NA; Khan AH; Johns EJ
Acta Pharmacol Sin; 2008 Apr; 29(4):451-7. PubMed ID: 18358091
[TBL] [Abstract][Full Text] [Related]
43. Temporal changes in the expression of TGF-beta 1 and EGF in the ventral horn of the spinal cord and associated precentral gyrus in adult Rhesus monkeys subjected to cord hemisection.
Li XL; Liu J; Wang XY; Li LY; Ni W; Zheng RY; Yang HJ; Lu YC; Qi JG; Wang TH
J Neurol Sci; 2008 May; 268(1-2):163-71. PubMed ID: 18191945
[TBL] [Abstract][Full Text] [Related]
44. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta (TGF beta) activity in urine of patients with glomerulonephritis.
Dominguez GC; Costa RS; Dantas M; Kimachi T; Coimbra TM
Braz J Med Biol Res; 1995 Oct; 28(10):1061-4. PubMed ID: 8634677
[TBL] [Abstract][Full Text] [Related]
46. [Activity of cathepsin B and collagenase in urine and excretion of fibronectin and TGF-beta 1 in urine of patients with membranous glomerulonephritis].
Senatorski G; Paczek L; Sułowicz W; Gradowska L; Bartłomiejczyk I
Pol Arch Med Wewn; 1997 Sep; 98(9):206-12. PubMed ID: 9557072
[TBL] [Abstract][Full Text] [Related]
47. [Renal excretion of glucose and electrolytes in hyperglycemia continuously stabilized by controlled glucose perfusion. A study of normal and diabetic subjects].
Mirouze J; Selam JL; Mendoza E; Pham TC; Lapinski H
Union Med Can; 1980 Nov; 109(11):1630-6. PubMed ID: 7210306
[No Abstract] [Full Text] [Related]
48. Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis.
Senatorski G; Paczek L; Sułowicz W; Gradowska L; Bartłomiejczyk I
Res Exp Med (Berl); 1998 Dec; 198(4):199-206. PubMed ID: 9879598
[TBL] [Abstract][Full Text] [Related]
49. Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes.
Feillet-Coudray C; Choné F; Michel F; Rock E; Thiéblot P; Rayssiguier Y; Tauveron I; Mazur A
Clin Chim Acta; 2002 Oct; 324(1-2):25-30. PubMed ID: 12204421
[TBL] [Abstract][Full Text] [Related]
50. [Remarks on urinary glucose output during hyperglycemia maintained by intravenous perfusion].
MAZABRAUD J
C R Hebd Seances Acad Sci; 1962 Apr; 254():3247-9. PubMed ID: 14471786
[No Abstract] [Full Text] [Related]
51. Mode of action of the hyperglycemic-glycogenolytic factor from urine.
MOYA F
Endocrinology; 1955 Mar; 56(3):312-21. PubMed ID: 14353043
[No Abstract] [Full Text] [Related]
52. Study of the hyperglycemic activity of normal human urine.
MOYA F
Endocrinology; 1955 Sep; 57(3):322-8. PubMed ID: 13251237
[No Abstract] [Full Text] [Related]
53. Identification of a hyperglycemic factor in urine.
MOYA F; SZERB JC; MACINTOSH M
Can J Biochem Physiol; 1956 May; 34(3):563-70. PubMed ID: 13316583
[No Abstract] [Full Text] [Related]
54. [Hyperglycemia in adults].
Chaput A
Inf Dent; 1968 Jan; 50(1):36-8. PubMed ID: 5239709
[No Abstract] [Full Text] [Related]
55. [Hyperglycemia].
Berenski S; Abrahamov A
Harefuah; 1977 Jan; 92(1):26-7. PubMed ID: 844725
[No Abstract] [Full Text] [Related]
56. Transforming Growth Factorβ1 Overexpression Is Associated with Insulin Resistance and Rapidly Progressive Kidney Fibrosis under Diabetic Conditions.
D'Alessandro VF; Takeshita A; Yasuma T; Toda M; D'Alessandro-Gabazza CN; Okano Y; Tharavecharak S; Inoue C; Nishihama K; Fujimoto H; Kobayashi T; Yano Y; Gabazza EC
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430743
[TBL] [Abstract][Full Text] [Related]
57. TGFβ1 Induces Senescence and Attenuated VEGF Production in Retinal Pericytes.
Avramovic D; Archaimbault SA; Kemble AM; Gruener S; Lazendic M; Westenskow PD
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740425
[TBL] [Abstract][Full Text] [Related]
58. Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.
Gelbard MK; Rosenbloom J
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00195. PubMed ID: 33855203
[TBL] [Abstract][Full Text] [Related]
59. Dietary inflammatory potential, oxidative balance score, and risk of breast cancer: Findings from the Sister Study.
Park YM; Shivappa N; Petimar J; Hodgson ME; Nichols HB; Steck SE; Hébert JR; Sandler DP
Int J Cancer; 2021 Aug; 149(3):615-626. PubMed ID: 33783833
[TBL] [Abstract][Full Text] [Related]
60. Vascular endothelium dysfunction: a conservative target in metabolic disorders.
Jamwal S; Sharma S
Inflamm Res; 2018 May; 67(5):391-405. PubMed ID: 29372262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
